Screener
Bio-Rad Laboratories BIO Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Bio-Rad Laboratories in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The source filing: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 4:19 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000012208-26-000035
| LIABILITIES AND STOCKHOLDERS’ EQUITY | March 31, 2026 / (Unaudited) | December 31, 2025 |
|---|---|---|
| Class A common stock, $0.0001 par value; 80,000,000 shares authorized; shares issued - 25,199,880 and 25,199,760 as of March 31, 2026 and December 31, 2025, respectively; shares outstanding - 21,762,498 and 21,924,284 as of March 31, 2026 and December 31, 2025, respectively | — | — |
| Class B common stock, $0.0001 par value; 20,000,000 shares authorized; shares issued and outstanding - 5,065,990 as of March 31, 2026 and 5,066,110 as of December 31, 2025, respectively | — | — |
| Additional paid-in capital | 490.5 | 476.0 |
| Class A treasury stock at cost, 3,437,382 and 3,275,476 shares as of March 31, 2026 and December 31, 2025, respectively | (1,053.0) | (1,009.6) |
| Retained earnings | 7,649.2 | 8,176.3 |
| Accumulated other comprehensive income (loss) | (235.4) | (189.1) |
| Total stockholders’ equity | 6,851.3 | 7,453.6 |
| Total liabilities and stockholders’ equity | $9,790.0 | $10,576.5 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Bio-Rad Laboratories's total equity?
- Bio-Rad Laboratories (BIO) reported total equity of $6.85B in Q1 2026.
- How has Bio-Rad Laboratories's total equity changed year-over-year?
- Bio-Rad Laboratories's total equity increased by 2.6% year-over-year, from $6.68B to $6.85B.
- What is the long-term trend for Bio-Rad Laboratories's total equity?
- Over 5 years (2020 to 2025), Bio-Rad Laboratories's total equity has grown at a -5.5% compound annual growth rate (CAGR), from $9.89B to $7.45B.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.
Ask your AI about Bio-Rad Laboratories's total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude